Search Results - "Novikova, O. Yu"

Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study by M.   Yu. Fedyanin, F.   V. Moiseenko, M.   A. Lyadova, V.  N.  Vorobyeva, V.  V.  Petkau, A.  V.  Fateeva, E.  S.  Kuzmina, O.  Yu.  Novikova, V.   A. Chubenko, N.  Kh.  Abduloeva, A.  A.  Kudryavtsev, E.   O. Ignatova, R.   R. Shakirov, O.  A.  Pardabekova, L.  V.  Kindyalova, S.  P.  Pelikh, O.   A. Gladkov, S.  A.  Tjulandin, A.  A.  Tryakin

“…Objective: to compare the efficacy and tolerability of second‑line chemotherapy with original bevacizumab (Avastin) and biosimilar bevacizumab produced by…”
Get full text

Efficacy and toxicity of aflibercept and bevacizumab in combination with FOLFIRI in second‑line therapy for metastatic colon cancer: a retrospective multicenter study by M.   Yu. Fedyanin, L.  Yu.  Vladimirova, V.  A.  Chubenko, L.   A. Zagorskaya, A.  V.  Belyaeva, O.  L.  Fakhrutdinova, S.  A.  Belukhin, A.   S. Zhabina, L.   V. Khalikova, L.  V.  Bolotina, R.   V. Orlova, F.  V.  Moiseenko, G.   Z. Mukhametshina, A.  I.  Khasanova, A.  V.  Belonogov, Kh.  S.  Musaeva, O.  Yu.  Novikova, I.  Yu.  Stradaeva, I.  L.  Popova, S.  P.  Erdniev, A.  K.  Ivanova, A.  V.  Androsova, P.  S.  Feoktistova, E.  S.  Kuzmina, E.   V. Karabina, O.  V.  Nekrasova, O.  V.  Sekhina, A.   A. Mishchenko, L.  A.  Mukova, B.  Kh.  Kertiev, G.  I.  Kosar, S.   N. Osodoeva, A.  I.  Kats, R.  R.  Malina, M.  A.  Lyadova, A.  A.  Tryakin, S.  A.  Tyulandin

“…Objective: to compare the efficacy and toxicity of aflibercept and bevacizumab in combination with fOLfIRI in secondline therapy for patients with metastatic…”
Get full text

CHARACTERISTICS OF NATIVE AND CRYOPRESERVED CULTURE OF DERMAL PAPILLA OF NEWBORN RABBITS VIBRISSA by Novikova, O. Yu, Bondarenko, T. P.

Get full text

Factors associated with efficacy of FOLFIRI/aflibercept in patients with metastatic colon cancer by Fedyanin, M. Yu, Vladimirova, L. Yu, Chubenko, V. A., Zagorskaya, L. A., Belyaeva, A. V., Bolotina, L. V., Moiseenko, F. V., Fakhrutdinova, O. L., Belukhin, S. A., Zhabina, A. S., Khalikova, L. V., Moiseenko, V. M., Meshcheryakov, А. А., Artamonova, E. V., Pokataev, I. A., Khasanova, A. I., Belonogov, A. V., Musaeva, Kh. S., Novikova, O. Yu, Stradaeva, I. Yu, Popova, I. L., Mukhametshina, G. Z., Orlova, R. V., Erdniev, S. P., Ivanova, A. K., Androsova, A. V., Feoktistova, P. S., Kuzmina, E. S., Karabina, E. V., Nekrasova, O. V., Sherstnev, V. M., Mishchenko, A. A., Mukova, L. A., Kertiev, B. Kh, Kosar, G. I., Osodoeva, S. N., Kats, A. I., Malina, R. R., Tryakin, A. A., Tjulandin, S. A.

“…Objective: to identify factors associated with efficacy of an aflibercept-chemotherapy combination in patients with metastatic colon cancer.Materials and…”
Get full text

Combination of atezolizumab and bevacizumab in patients with inoperable hepatocellular cancer in real clinical practice by Petkau, V. V., Shemetov, D. Yu, Semenova, K. O., Chubenko, V. A., Sultanbaev, A. V., Menshikov, K. V., Novikova, O. Yu, Orlova, R. V., Popova, N. V., Antipin, A. S., Mukhitova, M. R., Tarkhanov, A. A., Kiseleva, K. E.

“…Introduction . In the structure of Russian cancer incidence, malignant neoplasms (MN) of the liver occupy 1.61%. Patients with initially unresectable…”
Get full text

The development and researching of lightweight pseudorandom number generators by Chugunkov, I. V., Novikova, O. Yu, Perevozchikov, V. A., Troitskiy, S. S.

“…The paper is devoted to the development and quality assessment of lightweight pseudo-random number generators (PNRG). The design principles of lightweight PRNG…”
Get full text